Second-Quarter Year-Over-Year Highlights: - Record GAAP diluted EPS increased 34.2 percent to $0.51 from $0.38 in
second-quarter 2007
- Record diluted EPS increased 30.2 percent to $0.56 from $0.43 in second-quarter 2007, excluding $0.05 in amortization of intangible assets
from the 2003 spin-off
- Net revenues increased 15.6 percent to nearly $12.8 billion - Specialty revenues increased 32.6 percent to a record of nearly $2.0
billion - Mail-order prescription volume of 26.3 million increased 2.8 million, or
11.9 percent, from 23.5 million in second-quarter 2007 - Record generic dispensing rate of 63.7 percent increased 4.8 percentage
points from second-quarter 2007
Raised and Narrowed 2008 Guidance:
- Full-year GAAP diluted EPS guidance is raised to $2.10 to $2.13, reflecting growth of 29 to 31 percent over 2007, up from previous guidance
of $2.07 to $2.11 per share - Full-year diluted EPS guidance, excluding amortization of intangible assets, is raised to $2.30 to $2.33, reflecting growth of 26 to 28 percent over 2007, up from previous guidance of $2.27 to $2.31 per share (Please
see Table 9 for a reconciliation of earnings per share guidance).
FRANKLIN LAKES, N.J., July 24 /PRNewswire-FirstCall/ -- Driven by
record 2008 sales performance across the company, including Accredo Health
Group, and strong fundamentals, Medco Health Solutions, Inc. (NYSE: MHS)
today reported a 34.2 percent increase in second-quarter 2008 GAAP diluted
earnings per share to $0.51, compared to $0.38 for the second quarter
'/>"/>
| SOURCE Medco Health Solutions, Inc. Copyright©2008 PR Newswire. All rights reserved |